Main Session
Sep
29
SS 27 - Breast Cancer 2: Multimodal Strategies in Breast Cancer: Biology, Systemic Therapy, and Psychosocial Insights
262 - Safety and Potential Radiosensitizing Effect of Olaparib in Combination with Breast Radiotherapy for TNBC Patients with Residual Disease: Long-Term Results from a Phase I Trial
Presenter(s)
Pierre Loap, MD - Institut Curie, Paris, Ile de France